AGN-151607-DP
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGN-151607-DP, covering 2026-04-06 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair [Phase 2]